This month & next are expected to be definitive months for TIS. The last announcement was (i believe)unusually specific about a deal being announced in November so I'd imagine people will start moving in over the next few weeks to get a position before any announcement on partnerships.
This month itself is expected to bring us the full results from the latest EU trial and ideally these will build on the great results highlighted already.
Also i don't think anyone should underestimate the value to us of FDA Device classification either - without it we will be looking at a much longer/harder road to US Sales. A positive outcome in this regard will be a big deal for us and we're expected to know one way or the other by the end of this month.
Even if this rally doesn't last, unless we see a complete collapse of the markets, i think TIS will be going into 2012 with a bigger and brighter future. My opinion and speculation only.
Regards
DYOR GLTA
TIS Price at posting:
48.0¢ Sentiment: Buy Disclosure: Held
